Esther Sala

452 total citations
14 papers, 367 citations indexed

About

Esther Sala is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Esther Sala has authored 14 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Esther Sala's work include Peroxisome Proliferator-Activated Receptors (5 papers), Natural Antidiabetic Agents Studies (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Esther Sala is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Natural Antidiabetic Agents Studies (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Esther Sala collaborates with scholars based in Spain, United States and Switzerland. Esther Sala's co-authors include Gerard Pujadas, Laura Guasch, Santiago Garcı́a-Vallvé, Miquel Mulero, Cristina Valls, Anna Ardèvol, Mayte Blay, M. Josepa Salvadó, Lluı́s Arola and Cinta Bladé and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Hypertension.

In The Last Decade

Esther Sala

14 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esther Sala Spain	11	208	83	55	51	51	14	367
Ruth Vrolix Netherlands	5	227 1.1×	94 1.1×	25 0.5×	34 0.7×	97 1.9×	5	597
Yi Qu China	8	162 0.8×	56 0.7×	21 0.4×	27 0.5×	24 0.5×	13	402
Debasish Roy India	10	182 0.9×	106 1.3×	12 0.2×	39 0.8×	78 1.5×	14	419
Jia Lv China	9	196 0.9×	49 0.6×	17 0.3×	29 0.6×	16 0.3×	20	422
A.-K. Riethling Germany	4	185 0.9×	95 1.1×	25 0.5×	33 0.6×	232 4.5×	5	542
Madhumitha Kedhari Sundaram Saudi Arabia	12	421 2.0×	37 0.4×	28 0.5×	59 1.2×	72 1.4×	15	637
Lele Ding China	8	131 0.6×	53 0.6×	51 0.9×	30 0.6×	21 0.4×	12	338
Ricardo Amorim Portugal	13	176 0.8×	33 0.4×	33 0.6×	14 0.3×	31 0.6×	19	356
Ram Chandra Gupta India	13	160 0.8×	42 0.5×	36 0.7×	88 1.7×	24 0.5×	41	565
Sivalokanathan Sarveswaran United States	10	172 0.8×	44 0.5×	12 0.2×	37 0.7×	22 0.4×	14	437

Countries citing papers authored by Esther Sala

Since Specialization

Citations

This map shows the geographic impact of Esther Sala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Sala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Sala more than expected).

Fields of papers citing papers by Esther Sala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Sala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Sala. The network helps show where Esther Sala may publish in the future.

Co-authorship network of co-authors of Esther Sala

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Sala. A scholar is included among the top collaborators of Esther Sala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Sala. Esther Sala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Naughton, M., et al.. (2018). Decarboxylation of Ang-(1–7) to Ala1-Ang-(1–7) leads to significant changes in pharmacodynamics. European Journal of Pharmacology. 833. 116–123. 25 indexed citations

Naughton, M., et al.. (2017). Abstract P237: The At2 Receptor Agonist, C21, Can Also Stimulate Mas and Mrgd Receptors. Hypertension. 70(suppl_1). 2 indexed citations

Guasch, Laura, Esther Sala, Miquel Mulero, et al.. (2013). Identification of PPARgamma Partial Agonists of Natural Origin (II): In Silico Prediction in Natural Extracts with Known Antidiabetic Activity. PLoS ONE. 8(2). e55889–e55889. 24 indexed citations

Guasch, Laura, María José Ojeda, Noemi González‐Abuín, et al.. (2012). Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays. PLoS ONE. 7(9). e44971–e44971. 39 indexed citations

Guasch, Laura, Esther Sala, Cristina Valls, et al.. (2012). Development of docking-based 3D-QSAR models for PPARgamma full agonists. Journal of Molecular Graphics and Modelling. 36. 1–9. 10 indexed citations

Guasch, Laura, Esther Sala, Anna Castell‐Auví, et al.. (2012). Identification of PPARgamma Partial Agonists of Natural Origin (I): Development of a Virtual Screening Procedure and In Vitro Validation. PLoS ONE. 7(11). e50816–e50816. 45 indexed citations

Guasch, Laura, Esther Sala, María José Ojeda, et al.. (2012). Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts. PLoS ONE. 7(9). e44972–e44972. 18 indexed citations

Sala, Esther, Laura Guasch, Justyna Iwaszkiewicz, et al.. (2011). Identification of Human IKK-2 Inhibitors of Natural Origin (Part I): Modeling of the IKK-2 Kinase Domain, Virtual Screening and Activity Assays. PLoS ONE. 6(2). e16903–e16903. 23 indexed citations

Sala, Esther, Laura Guasch, Justyna Iwaszkiewicz, et al.. (2011). Identification of human IKK-2 inhibitors of natural origin (Part II): In Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity. European Journal of Medicinal Chemistry. 46(12). 6098–6103. 20 indexed citations

10.

Guasch, Laura, Esther Sala, Cristina Valls, et al.. (2011). Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity. Journal of Computer-Aided Molecular Design. 25(8). 717–728. 48 indexed citations

11.

Bas-Prior, Josep M Del, Marie‐Louise Ricketts, Esther Sala, et al.. (2009). Dietary procyanidins enhance transcriptional activity of bile acid‐activated FXR in vitro and reduce triglyceridemia in vivo in a FXR‐dependent manner. Molecular Nutrition & Food Research. 53(7). 805–814. 80 indexed citations

12.

Puiggròs, Francesc, Esther Sala, Anna Ardèvol, et al.. (2009). In Vivo, in Vitro, and in Silico Studies of Cu/Zn-Superoxide Dismutase Regulation by Molecules in Grape Seed Procyanidin Extract. Journal of Agricultural and Food Chemistry. 57(9). 3934–3942. 28 indexed citations

13.

Sala, Esther, Laura Guasch, Josep M. Mateo‐Sanz, et al.. (2009). 3D‐QSAR Study of Pyridine Derivates as IKK‐2 Inhibitors. QSAR & Combinatorial Science. 28(6-7). 678–695. 2 indexed citations

14.

Clarkson, B, et al.. (1967). Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.. PubMed. 27(11). 2129–36. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact